Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphoma, Mantle-Cell × Immunoglobulins × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 3 Neoplasms 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hematologic Neoplasms 1 Burkitt Lymphoma 1

Interventions

Rituximab 107 Cyclophosphamide 95 fludarabine phosphate 45 Peripheral Blood Stem Cell Transplantation 44 Cytarabine 43 Etoposide 39 Mycophenolic Acid 37 Filgrastim 36 Whole-Body Irradiation 34 Bortezomib 32 Tacrolimus 31 Methotrexate 31 Melphalan 29 Cyclosporine 29 Radiotherapy 28 Vincristine 27 Busulfan 27 Doxorubicin 26 Dexamethasone 26 Antilymphocyte Serum 23 Carmustine 22 Bendamustine Hydrochloride 22 Lenalidomide 21 ibrutinib 20 Granulocyte Colony-Stimulating Factor 17 fludarabine 16 Prednisone 16 zanubrutinib 15 venetoclax 15 obinutuzumab 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05910801 2024-11-18

V-MIND

Academic and Community Cancer Research United

Phase 2 Recruiting

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡